Web Analytics Made Easy - StatCounter
Category

Skin Cancer

Dangerous plants in dermatology: Legal and controlled.

By | Cancer, Inflammation, Skin Cancer, Skin Diseases

Authors: Deeptej Singh, Juliya Fisher, Devorah Shagalov, Aakaash Varma, Daniel M. Siegel
Clinics in Dermatology, May-June 2018

The plant and mushroom kingdoms have species used for intoxication, inebriation, or recreation. Some of these species are toxic. Given that many of these plants or substances are illegal and have histories of abuse, much of the research regarding therapeutic application is bas…

Read More

Standardized Cannabis sativa extract attenuates tau and stathmin gene expression in the melanoma cell line.

By | Cancer, Skin Cancer

Authors: Golnaz Vaseghi, Mohamad Javad Taki, Shaghayegh Haghjooy Javanmard
Iranian journal of basic medical sciences, October 2017

OBJECTIVES: Metastasis is the main cause of death in patients with melanoma. Cannabis-based medicines are effective adjunctive drugs in cancer patients. Tau and Stathmin proteins are the key proteins in cancer metastasis. Here we have investigated the effect of a standardized…

Read More

The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas.

By | Cancer, Skin Cancer

Authors: E Pérez-Gómez, C Andradas, J M Flores, M Quintanilla, J M Paramio, M Guzmán, C Sánchez
Oncogene, 16 May 2013

G protein-coupled receptors (GPCRs) control crucial physiological processes and their dysfunction contributes to various human diseases, including cancer. The orphan GPCR GPR55 was identified and cloned more than a decade ago, but very little is known about its physio-patholog…

Read More

Cannabinoids for cancer treatment: progress and promise.

By | Brain Cancer, Breast Cancer, Cancer, Lymphoma, Pancreatic Cancer, Prostatic Cancer, Skin Cancer

Authors: Sami Sarfaraz, Vaqar M. Adhami, Deeba N. Syed, Farrukh Afaq, Hasan Mukhtar
Cancer Research, 15 January 2008

Cannabinoids are a class of pharmacologic compounds that offer potential applications as antitumor drugs, based on the ability of some members of this class to limit inflammation, cell proliferation, and cell survival. In particular, emerging evidence suggests that agonists of…

Read More